What Lyme is
Lyme disease is a bacterial tick-borne infection (commonly Borrelia burgdorferi in the US). Early disease and later disseminated disease differ. Co-infections exist and should be named carefully — not used as an excuse for endless stacked drugs.
Post-treatment Lyme disease syndrome (PTLDS) and community “chronic Lyme” labels are not identical. This Guide separates active infection care from lingering symptom / post-infectious care and from marketing that collapses them.
What we do not claim: that Regenerated endorses one specialty society over another, or that a regenerative protocol eradicates Borrelia.
### Why care shopping is hazardous
Guideline debates are real. Patients get caught between short antibiotic courses and multi-year IV regimens. The same fatigue/cognitive picture also shows up in ME/CFS, Long COVID, and mold-related illness — so mislabeling is common.
See companion [toxic mold / CIRS-aware Guide](/conditions/toxic-mold-exposure), [ME/CFS](/conditions/chronic-fatigue-syndrome), and [Long COVID](/conditions/long-covid). Overlap is not identity.
Symptoms and presentation patterns
| Cluster | More Lyme-typical early | More overlap / nonspecific |
|————-|————————————-|——————————————|
| Skin | Erythema migrans (not always present) | — |
| Systemic | Flu-like, fever, malaise | Fatigue, brain fog |
| Joint / neuro | Arthritis, facial palsy, meningitis patterns | Widespread pain, cognitive complaints |
Presentation varies. Absence of a classic rash does not automatically rule Lyme in or out. Nonspecific fatigue and cognitive complaints alone are not a reason to skip differentials.
How diagnosis usually works
Two-tier serology has limits; clinical judgment matters for early disease. Negative tests do not automatically mean “start endless IV antibiotics,” and positive specialty panels do not automatically mean “cure with peptides.”
Ask what would change management. Document exposure timeline, early vs later features, prior treatment, and whether symptoms fit a post-treatment pattern, another infection, mold/building exposure, PEM-pattern illness, or something else.
Conventional care baseline
Appropriate antibiotics for acute Lyme when indicated; monitoring for adverse effects (including C. diff risk on prolonged therapy)
- Infectious disease involvement for complicated or neurologic disease
- For lingering symptoms after standard treatment: evaluate differentials (including PEM-pattern illness, autoimmune, endocrine, sleep, mold exposure) rather than protocol loyalty alone
This Guide does not trash conventional care. Gaps appear when clinics dismiss lingering symptoms, refuse differentials, or oversell unproven eradication packages.
Regenerative and integrative options — evidence-graded
We use working grades: Stronger · Mixed / emerging · Supportive / adjunct · Speculative / clinic-marketed. Language rule: prefer “may help some people” over “works.” Separate FDA regulatory status from marketing claims. Acute antibiotic care when indicated is the established baseline — regenerative options below are not eradication therapies.
#### Supportive care (sleep, pacing if PEM, nutrition, autonomic) — Supportive / adjunct
Sleep, pacing when post-exertional malaise is present, nutrition, and autonomic-aware support may help the recovery environment for some people. They are not Borrelia eradication.
Directory: [Browse clinics](/clinics)
#### Hyperbaric oxygen therapy (HBOT) — Limited / case-level for Lyme — not eradication
Some clinics list HBOT for Lyme-related symptoms. Evidence for Lyme eradication is not established. Treat as adjunct shopping terrain only.
Learn the modality: [Hyperbaric oxygen therapy (HBOT)](/treatments/hbot)
- Find clinics: [Find HBOT clinics](/clinics/t/hbot)
#### Herbals / extended antimicrobials beyond guidelines — Caution
Drug-interaction and resistance risks matter. Herbals are not “stronger than antibiotics.” Ask for stop criteria, monitoring, and what would change management.
#### Stem cell therapy, exosomes, and peptides — Speculative / clinic-marketed
Cellular and peptide products are heavily misused in this vertical. For Lyme they should be treated as investigational / insufficient evidence for eradication claims. FDA approval in one context is not approval to claim Lyme cure.
Treatment literacy: [Stem cell therapy](/treatments/stem-cell-therapy)
- Directory: [Find stem cell therapy clinics](/clinics/t/stem-cell-therapy) (filter and vet carefully; listing ≠ endorsement of Lyme claims)
#### Ozone / “detox” stacks — Red-flag literacy, not a modality CTA
Do not promote ozone or detox stacks as standard Lyme care. Prefer red-flag literacy over Directory endorsement of these funnels.
Primary Directory actions (required CTAs):
Find clinics — browse the national Directory and filter by treatments relevant to your plan:
[Browse all clinics](/clinics) use treatment filters; do not treat Featured/paid placement as clinical superiority
> - [Find HBOT clinics](/clinics/t/hbot) (adjunct framing only)
> - Companion Guide: [Toxic mold exposure / CIRS-aware care](/conditions/toxic-mold-exposure)
We do not list “best clinics” inside this Guide. `score ≠ spend`.
Red flags and shopping hazards
Walk away — or slow way down — if you see:
Cure guarantees for “chronic Lyme”
- Unmonitored long-term IV antibiotics as default
- Clinics that refuse differential diagnosis
- Stem cells / peptides sold as Lyme cures
- Protocol loyalty tests (“if you question the stack, you’re not ready”)
- Ignoring mold/building exposure when the history fits both
- Any implication that paid Directory placement means better clinical quality
### Questions to ask a clinician
Are we treating active infection, post-treatment syndrome, mold/CIRS framework, or an open differential?
2. What tests will you run, and what would change management if negative?
3. For antibiotics: drug, duration, monitoring, and stop criteria?
4. Do you address environmental exposure before or alongside expensive protocols?
5. Which therapies are guideline-supported vs exploratory, and what are the risks?
6. How do you handle co-infections without endless stacking?
7. What functional outcomes define “enough improvement”?
Finding clinics (Directory CTA)
If you are ready to look at options, use the Directory — not a Guide listicle.
[Browse clinics →](/clinics)
[HBOT clinics →](/clinics/t/hbot) (adjunct framing only)
[Companion: Toxic mold / CIRS-aware Guide →](/conditions/toxic-mold-exposure)
Learn how we approach listings: [How we vet clinics](/about/how-we-vet-clinics). Featured labels, when present, are commercial chrome — not a clinical ranking.
Related reading
Sibling Guides (evergreen):
[Toxic mold exposure / CIRS-aware care](/conditions/toxic-mold-exposure) — bidirectional companion in this D-03 package
- [ME/CFS / chronic fatigue syndrome](/conditions/chronic-fatigue-syndrome) PEM-centered literacy when fatigue/cognitive picture overlaps
- [Long COVID](/conditions/long-covid) related complex-illness shopping patterns
Treatments:
[HBOT](/treatments/hbot) · [Stem cell therapy](/treatments/stem-cell-therapy)
Blog: use only for news / FDA / timely updates. Blog Lyme / ozone-for-Lyme posts should link to this Guide + Directory — not act as a second evergreen Guide (D-02). Do not let Blog titles clone this H1.
